Longitudinal Outcomes of Dolutegravir-based Antiretroviral Therapy in a Large Nigerian Programmatic HIV Cohort, 2017–2019
In a retrospective Nigerian cohort of 33,982 PLHIV initiating or switching to TLD, virological suppression reached 80–82% among participants with available viral load data and 63–65% by intention-to-treat analysis. Suppression was higher among switchers, while age and gender predicted suppression.
Authors
- Adam Abdullahi (ORCID: https://orcid.org/0000-0001-9703-8264)
- Ravindra Gupta
Publication Details
- Journal
- Apollo
- Published
- 2026-08-27
- DOI
- https://doi.org/10.17863/cam.133573
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00